open access

Vol 74, No 3 (2023)
Clinical vignette
Submitted: 2023-01-15
Accepted: 2023-02-21
Published online: 2023-05-08
Get Citation

Adverse outcome of T3-predominant maternal Grave’s disease during pregnancy in the mother and the offspring

Aleksandra Mikołajczak1, Renata Bokiniec2, Agnieszka Sienicka3, Agata Pisula3, Ewa Romejko-Wolniewicz4
·
Pubmed: 37155306
·
Endokrynol Pol 2023;74(3):340-341.
Affiliations
  1. Neonatal Department, Collegium Medicum of Cardinal Stefan Wyszynski University, Warsaw, Poland
  2. Neonatal and Intensive Care Department, Medical University of Warsaw, Warsaw, Poland
  3. Students’ Scientific Group affiliated to the 2nd Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland
  4. 2nd Department of Obstetrics and Gynaecology, Medical University of Warsaw, Warsaw, Poland

open access

Vol 74, No 3 (2023)
Clinical Vignette
Submitted: 2023-01-15
Accepted: 2023-02-21
Published online: 2023-05-08

Abstract

Note required for Clinical Vignette.

Abstract

Note required for Clinical Vignette.

Get Citation

Keywords

hyperthyroidism; neonatal; pregnancy; T3-predominant Grave’s disease

About this article
Title

Adverse outcome of T3-predominant maternal Grave’s disease during pregnancy in the mother and the offspring

Journal

Endokrynologia Polska

Issue

Vol 74, No 3 (2023)

Article type

Clinical vignette

Pages

340-341

Published online

2023-05-08

Page views

1375

Article views/downloads

352

DOI

10.5603/EP.a2023.0031

Pubmed

37155306

Bibliographic record

Endokrynol Pol 2023;74(3):340-341.

Keywords

hyperthyroidism
neonatal
pregnancy
T3-predominant Grave’s disease

Authors

Aleksandra Mikołajczak
Renata Bokiniec
Agnieszka Sienicka
Agata Pisula
Ewa Romejko-Wolniewicz

References (5)
  1. Fujishima A, Sato A, Miura H, et al. Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report. BMC Pregnancy Childbirth. 2020; 20(1): 344.
  2. Harvengt J, Boizeau P, Chevenne D, et al. Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications. Eur J Endocrinol. 2015; 172(6): 715–723.
  3. Léger J, Carel JC. Diagnosis and management of hyperthyroidism from prenatal life to adolescence. Best Pract Res Clin Endocrinol Metab. 2018; 32(4): 373–386.
  4. Nguyen CT, Sasso EB, Barton L, et al. Graves' hyperthyroidism in pregnancy: a clinical review. Clin Diabetes Endocrinol. 2018; 4: 4.
  5. Mikołajczak A, Borszewska-Kornacka MK, Bokiniec R. Sonographic Reference Ranges for the Thyroid Gland in Euthyroid Term Newborns. Am J Perinatol. 2015; 32(13): 1257–1262.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl